Hazel O’Sullivan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
- Inflammatory Biomarkers in Disease Prognosis 1
- Cutaneous Melanoma Detection and Management 1
-
- Epigenetics and DNA Methylation 1
- Co-authors
- Fergal C. Kelleher (5 shared papers)Elizabeth Smyth (1 shared paper)Ray McDermott (1 shared paper)Delwood C. Collins (1 shared paper)Stuart A. Grossman (1 shared paper)Richard Bambury (2 shared papers)Derek G. Power (2 shared papers)Séamus O’Reilly (2 shared papers)
- Journals
- Journal of Adolescent and Young Adult Oncology (1 paper)Clinical Cancer Research (1 paper)Oncotarget (1 paper)Carcinogenesis (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- IrelandNew ZealandUnited Kingdom
In The Last Decade
Hazel O’Sullivan
9 papers receiving 299 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 59
- Oncology 77
- Molecular Biology 170
- Immunology 37
- Cell Biology 23
Countries citing papers authored by Hazel O’Sullivan
This map shows the geographic impact of Hazel O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel O’Sullivan more than expected).
Fields of papers citing papers by Hazel O’Sullivan
This network shows the impact of papers produced by Hazel O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel O’Sullivan. The network helps show where Hazel O’Sullivan may publish in the future.
Co-authors
The 16 scholars most cited alongside Hazel O’Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 114 | |
| 2 | 2017 | 57 | |
| 3 | 2019 | 52 | |
| 4 | 2016 | 51 | |
| 5 | 2024 | 13 | |
| 6 | 2013 | 8 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2017 | 1 | |
| 10 | 2022 | 0 |
About Hazel O’Sullivan
Hazel O’Sullivan is a scholar working on Oncology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 302 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Economic and Financial Impacts of Cancer (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Epigenetics and DNA Methylation (1 paper), Cancer Mechanisms and Therapy (1 paper), Immunotherapy and Immune Responses (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Cancer Research (59 citations), Oncology (77 citations), Molecular Biology (170 citations), Immunology (37 citations) and Cell Biology (23 citations). Hazel O’Sullivan has collaborated with scholars based in Ireland, New Zealand and United Kingdom. Frequent co-authors include Fergal C. Kelleher, Elizabeth Smyth, Ray McDermott, Delwood C. Collins, Stuart A. Grossman, Richard Bambury, Derek G. Power, Séamus O’Reilly, Michael Conroy and Helen M. Fenlon. Their work appears in journals such as Journal of Adolescent and Young Adult Oncology, Clinical Cancer Research, Oncotarget, Carcinogenesis and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.